Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas

Citation
M. Soderstrom et al., Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human chondrosarcomas, APMIS, 109(4), 2001, pp. 305-315
Citations number
35
Categorie Soggetti
Medical Research General Topics
Journal title
APMIS
ISSN journal
09034641 → ACNP
Volume
109
Issue
4
Year of publication
2001
Pages
305 - 315
Database
ISI
SICI code
0903-4641(200104)109:4<305:EOMMAT>2.0.ZU;2-I
Abstract
The aim of the present study was to characterise the ability of malignant c hondrosarcomas to invade normal bone by analysing their production of matri x metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TI MPs). For this purpose 12 chondrosarcomas were investigated for the express ion of mRNAs for several MMPs and all 4 TIMPs by Northern hybridisation, an d for immunohistochemical localisation of the proteins. A characteristic fi nding of these analyses was increased expression of MMP-13, MMP-14 and TIMP -2 mRNAs in chondrosarcomas when compared with nonmalignant control samples . Individual chondrosarcomas also exhibited elevated levels of MMP-1, MMP-7 and MMP-9 mRNAs. The results of Northern hybridisations were supported by immunohistochemical stainings of the corresponding tumour areas for MMP-2, MMP-14 and TIMP-2, further suggesting that these may have prognostic value for determining whether individual chondrosarcomas are locally aggressive o r have a probability of recurrence. Another finding of the present study wa s a marked heterogeneity in histologic appearance and gene expression of th e chondrosarcomas, emphasising the importance of analysing several areas of these tumours to get representative results. These findings suggest that a nalysis of MMPs could be a useful diagnostic indicator in patients with car tilaginous tumours and could help in differentiating between a low-grade ma lignant chondrosarcoma and a benign growing enchondroma.